US Stock MarketDetailed Quotes
JAGX Jaguar Health
- 0.1569
- -0.0202-11.41%
Close Apr 19 16:00 ET
- 0.1573
- +0.0004+0.25%
Post 18:18 ET
45.07MMarket Cap-87P/E (TTM)
0.1729High0.1535Low30.91MVolume0.1621Open0.1771Pre Close5.05MTurnover10.83%Turnover RatioLossP/E (Static)287.26MShares1.220052wk High9.23P/B44.77MFloat Cap0.051252wk Low--Dividend TTM285.34MShs Float1667925.0000Historical High--Div YieldTTM10.95%Amplitude0.0512Historical Low0.1630Avg Price1Lot Size
About Jaguar Health Company
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
Company Profile
SymbolJAGX
Company NameJaguar Health
Listing DateMay 13, 2015
Issue Price7.00
Founded2013
CEOMs. Lisa A. Conte
MarketNASDAQ
Employees49
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Pine Street,Suite 400
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94104
Phone1-415-371-8300
Websitehttp://www.jaguar.health
Company Executives
- Name
- Position
- Salary
- Lisa A. Conte
- Chief Executive Officer, President and Director
- 1.10M
- Carol R. Lizak
- Chief Financial Officer, Treasurer and Principal Accounting Officer
- --
- Pravin R. Chaturvedi, PhD
- Chief Scientific Officer
- 640.66K
- Jonathan S. Wolin
- Chief of Staff, General Counsel and Chief Compliance Officer
- 621.94K
- Ian H. Wendt
- Chief Commercial Officer
- 557.90K
- James J. Bochnowski
- Chairman of the Board
- 137.30K
- Dr. Anula Jayasuriya, M.B.A.,M.D.,PhD
- Independent Director
- 20.00K
- Jonathan B. Siegel
- Independent Director
- 103.61K
- John Micek III JD
- Independent Director
- 101.42K
- Dr. Steven R. King, PhD
- Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary
- 549.04K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg